Benefit
Benefit entitlement
Maximum cover
AIA Private Health Cover and AIA Private Health Plus
Costs for the surgical treatment of cancer are covered under the above Surgery benefit, as listed under Inpatient treatment costs and/or Outpatient treatment support costs. This benefit covers non-surgical cancer treatment costs up to the maximum cover for this benefit of the following treatments, procedures, consultations, tests, diagnostic imaging, support and care once a diagnosis of cancer has been made by a specialist .
CANCER CARE
Except where stated below to the contrary, the excess applies to any claims under this benefit.
Consultations with a specialist for treatment or procedures relating to the treatment of cancer .
Specialist consultations
Diagnostic imaging and tests and procedures in connection with the detection or treatment of cancer including:
CT, PET/CT and MRI scans
Ultrasounds
X-rays, scintigraphy
Mammography
Diagnostic imaging and tests
Colonoscopy
Laboratory tests
$500,000 per life assured per policy year , subject to maximums for specific treatments or procedures
Tumour genetic testing
Gastrointestinal endoscopy
Cystoscopy
Hysteroscopy
Diagnostic laparoscopy
Chemotherapy and immunotherapy treatment including targeted therapy, oral, intravenous infusion, instilled, and intraoperative chemotherapy provided by or under the direction of a specialist , whether administered in an approved facility or at home. This covers the cost of Pharmac and non-Pharmac subsidised MedSafe indicated cancer chemotherapy and immunotherapy drugs, subject to AIA criteria .
Chemotherapy/immunotherapy
This also includes the cost of materials, hospital accommodation and ancillary hospital charges .
Prior approval must be obtained before the treatment takes place.
Radiotherapy treatment provided by a specialist in an approved facility including planning, shielding and accessories, field setup and simulation, subject to AIA criteria.
Radiotherapy
Prior approval must be obtained before the treatment takes place.
Implantation of radioactive seeds for the treatment of malignancies of the prostate.
Prostate brachytherapy
Page 11 of 29
1300 APH-UMB version 7 Effective 12 May 2026
Powered by FlippingBook